GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases
GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases
Recruiting · NCT07122076 · Registry updated 2026-09-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases | autoimmune disease, immune system disorder | Recruiting | Early phase 1 | 2026-09-18 | NCT07122076 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Grit Biotechnology | 19 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai Changzheng Hospital | Shanghai | China | 8 |